Cagrilintide 5mg - Third-Party Test Results

Manufacturer: LeoLab™

Sample: Cagrilintide 5mg

Date: 25 MAR 2025

LeoLab’s Cagrilintide 5mg (Batch G60147) has recently undergone independent third-party testing by Janoshik Analytical, a trusted name in peptide quality control. The results reaffirm LeoLab’s commitment to high standards in peptide production and transparency.

Test Summary

  • Analyzed Sample: Cagrilintide 5mg

  • Batch Number: G60147

  • Purity: 99.516%

  • Measured Mass: 4.68 mg

  • Date of Analysis: 25 March 2025

  • Task ID: 60438

Review & Interpretation

The standout metric from the analysis is the exceptional purity of 99.516%, which comfortably exceeds industry benchmarks for pharmaceutical-grade peptides. This level of purity minimizes the risk of contaminants or byproducts, enhancing both safety and effectiveness in research and clinical applications.

The actual mass of 4.68 mg is consistent with the labeled dosage, indicating precise manufacturing and filling processes. This supports reliability in dosing, which is critical for consistent experimental or therapeutic outcomes.

Purity 99.516%

The Cagrilintide 5mg batch (G60147) was independently tested by Janoshik Analytical on 25 March 2025. The analysis confirmed a high purity level of 99.516%, ensuring exceptional quality, minimal impurities, and reliable performance for research and clinical use.

Mass 4.68 mg

During third-party testing by Janoshik Analytical on 25 March 2025, the measured mass of the Cagrilintide 5mg sample (Batch G60147) was confirmed to be 4.68 mg, verifying accurate dosing and consistent product formulation.
Gagrilinitide 5mg test results
 Verify Report
Category: Cagrilinitide Tests

More test results

Leave a Reply